Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-11-14 | Tango Therapeutics, Inc. | Rothenberg Mace
(Director) |
P | Common Stock | A | 20000 | $3.62 - $3.78 | $74,000 |
2024-11-06 | Tango Therapeutics, Inc. | EcoR1 Capital, LLC
(AtLeastTenPercentOwner) |
S | Common Stock | D | 2700000 | $2.92 - $3.29 | $8,435,742 |
2024-11-06 | Tango Therapeutics, Inc. | Davis Aaron I.
() |
S | Common Stock | D | 3080000 | $3.14 - $3.14 | $9,671,200 |
2024-10-25 | Tango Therapeutics, Inc. | Davis Aaron I.
() |
S | Common Stock | D | 633000 | $6.87 - $6.87 | $4,348,710 |
2024-10-21 | Tango Therapeutics, Inc. | Davis Aaron I.
() |
S | Common Stock | D | 875000 | $6.78 - $7.05 | $6,101,250 |
2024-09-13 | Tango Therapeutics, Inc. | TRV GP IV, LLC
(AtLeastTenPercentOwner) |
S | Common Stock | D | 67400 | $10.53 - $10.53 | $709,755 |
2024-09-05 | Tango Therapeutics, Inc. | TRV GP IV, LLC
(AtLeastTenPercentOwner) |
S | Common Stock | D | 75000 | $11.56 - $11.56 | $867,135 |
2024-08-16 | Tango Therapeutics, Inc. | TRV GP IV, LLC
(AtLeastTenPercentOwner) |
S | Common Stock | D | 285000 | $9.79 - $10.09 | $2,835,367 |
2024-07-30 | Tango Therapeutics, Inc. | TRV GP IV, LLC
(AtLeastTenPercentOwner) |
S | Common Stock | D | 235000 | $9.80 - $9.93 | $2,316,494 |
2024-07-18 | Tango Therapeutics, Inc. | TRV GP IV, LLC
(AtLeastTenPercentOwner) |
S | Common Stock | D | 191490 | $9.81 - $9.81 | $1,878,478 |
2024-07-17 | Tango Therapeutics, Inc. | TRV GP IV, LLC
(AtLeastTenPercentOwner) |
S | Common Stock | D | 550171 | $9.79 - $9.79 | $5,386,339 |
2024-06-28 | Tango Therapeutics, Inc. | Davis Aaron I.
() |
S | Common Stock | D | 234731 | $8.57 - $8.87 | $2,055,313 |
2024-06-06 | Tango Therapeutics, Inc. | Davis Aaron I.
() |
S | Common Stock | D | 140000 | $6.88 - $7.24 | $985,880 |
2024-06-05 | Tango Therapeutics, Inc. | Peters Malte
(Director) |
A | Common Stock | A | 6250 | $0.00 - $0.00 | $0 |
2024-06-05 | Tango Therapeutics, Inc. | Rothenberg Mace
(Director) |
A | Common Stock | A | 6250 | $0.00 - $0.00 | $0 |
2024-06-05 | Tango Therapeutics, Inc. | Calhoun Lesley Ann
(Director) |
S | Common Stock | A | 5000 | $7.21 - $7.21 | $36,039 |
2024-06-05 | Tango Therapeutics, Inc. | Calhoun Lesley Ann
(Director) |
A | Common Stock | A | 6250 | $0.00 - $0.00 | $0 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |